EPS HEALTH TECH (03860) announced its interim results for the six months ended September 30, 2025. The company recorded revenue of HK$224 million, a decrease of 35.44% year-on-year. Shareholders' attributable loss during the period was HK$4.073 million, compared to a profit of HK$14.684 million in the same period last year, marking a shift from profit to loss. The loss per share stood at HK$0.0078.

The decline in revenue from the apparel division was primarily attributed to reduced overall sales from key clients based in the U.S. and Europe. Notably, during the six-month period ended September 30, 2024, the group's largest client in this business segment ceased placing orders with the company in the current reporting period.